Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-03-2006 | Original Article

Lymphoscintigraphic sentinel node identification in patients with breast cancer: the role of SPECT-CT

Authors: H. Lerman, U. Metser, G. Lievshitz, F. Sperber, S. Shneebaum, E. Even-Sapir

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 3/2006

Abstract

Purpose

Lymph node status is a major factor in determining the stage, appropriate therapy and outcome in patients with breast cancer. It is therefore of clinical importance to accurately identify all sentinel nodes (SNs) for each individual tumour before surgery. The purpose of this study was to assess the role of SPECT-CT lymphoscintigraphy in SN identification in patients with breast cancer.

Methods

Lymphoscintigraphy comprising planar and SPECT-CT acquisition was performed in 157 consecutive patients with breast cancer (mean age 54.7±10.6, range 27–81 years) with a palpable mass (n=100), with a non-palpable mass (n=52) or post lumpectomy (n=5). Planar and SPECT-CT images were interpreted separately and the two imaging techniques were compared with respect to their ability to identify hot nodes.

Results

Planar imaging alone was negative for identification of hot nodes in 15% of the patients. SPECT-CT alone was negative in 10% and both techniques were negative in 9% of the patients. Forty-six of the total of 361 (13%) hot nodes identified by lymphoscintigraphy were detected only on SPECT-CT, including 21 nodes obscured by the scattered radiation from the injection site, nine adjacent nodes misinterpreted on planar images as a single node and 16 nodes which were missed on planar images and detected on SPECT data. SPECT-CT detected additional sites of drainage unexpected on planar images, including axillary (n=23 patients), internal mammary (n=5 patients), interpectoral (n=3 patients) and intramammary (n=2 patients) lymph node sites. Fourteen of the 329 (4%) hot lesions seen on planar images were false positive non-nodal sites of uptake that were accurately assessed by SPECT-CT and further validated by surgery. In a single patient, SPECT-CT was negative while planar images identified the SN.

Conclusion

SPECT-CT may improve the preoperative localisation of draining nodes in patients with breast cancer. It may detect hot nodes missed by planar imaging, exclude non-nodal false positive sites of uptake and accurately localise axillary and extra-axillary nodes.

Litvak DA, Giuliano AE. The results of the Department of Defense’s breast lymphatic mapping study [editorial]. Ann Surg Oncol2002;83:428–9CrossRef

McMasters KM, Giuliano AE, Ross MI, Reintgen DS, Hunt KK, Byrd DR, et al. Sentinel lymph node biopsy for breast cancer—not yet the standard care. N Engl J Med 1998;339:990–5CrossRefPubMed

Lauridsen MC, Garne JP, Sorensen FB, Melsen F, Lernevall A, Christiansen P. Sentinel lymph node biopsy in breast cancer—experience with the combined use of dye and radioactive tracer at Aarhus University Hospital. Acta Oncol 2004;43:20–5CrossRefPubMed

Mariani G, Erba P, Villa G, Gipponi M, Manca G, Boni G, et al. Lymphoscintigraphic and intraoperative detection of the sentinel lymph node in breast cancer patients: the nuclear medicine perspective. J Surg Oncol 2004;85:112–22CrossRefPubMed

Euhus DM, Peters GN, Leitch AM, Saboorian H, Mathews D, Erdman W, et al. Validating the performance of the mammary sentinel lymph node team. J Surg Oncol 2002;83:209–15CrossRef

Estourgie SH, Nieweg OE, Olmos RA Rutgers EJ, Kroon BB. Lymphatic drainage patterns from the breast. Ann Surg 2004;239: 232–7CrossRefPubMed

Alazraki NP, Styblo T, Grant SF, Cohen C, Larsen T, Aarvold JN. Sentinel node staging of early breast cancer using lymphoscintigraphy and intraoperative gamma detecting probe. Semin Nucl Med 2000;30:56–64PubMed

Lerch H, Jigalin A, Gasthaus K, Kunze K, Mainusch O, Lehmann P, et al. Three-dimensional localization of sentinel lymph nodes using combined emissiom and transmission SPECT. Clin Nucl Med 2003;28:1–4CrossRefPubMed

Keidar Z, Israel O, Krausz Y. SPECT/CT in tumor imaging: technical aspects and clinical applications. Semin Nucl Med 2003;33:205–18CrossRefPubMed

10.

Even-Sapir E, Lerman H, Lievshitz G, Khafif A, Fliss DM, Schwartz A, et al. Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. J Nucl Med 2003;44:1413–20PubMed

11.

Schneebaum S, Stadler J, Cohen M, Yaniv D, Baron J, Skornick Y. Gamma probe-guided sentinel node biopsy—optimal timing for injection. Eur J Surg Oncol 1998;24:515–9CrossRefPubMed

12.

Cody H III. Clinical aspects of sentinel node biopsy. Breast Cancer Res 2001;3:104–8CrossRefPubMed

13.

Martin RCG II, Edwards MJ, Wong SL, Tuttle TM, Carlson DJ, Brown CM, et al. Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study. Surgery 2000;128:139–44CrossRefPubMed

14.

Shivers S, Cox C, Leight G, Beauchamp D, Blumencranz P, Ross M, et al. Final results of the Department of Defense mulicenter breast lymphatic mapping trial. Ann Surg Oncol 2002;9:248–55CrossRefPubMed

15.

Alazraki N, Glass EC, Castronovo F, Olmos RA, Podoloff D. Procedure guideline for lymphoscintigraphy and the use of intraoperative gamma probe for sentinel lymph node localization in melanoma of intermediate thickness. J Nucl Med 2002;43:1414–8PubMed

16.

Sasa M, Nishitani H, Hori A, Morimoto T. Dynamic lymphoscintigraphy and image fusion of SPECT and pelvic CT-scans allow mapping of aberrant pelvic sentinel nodes. Anticancer Res 2003;23:2935–40PubMed

17.

Beitsch PD, Clifford E, Whitworth P, Abarca A. Improved lymphatic mapping technique for breast cancer. Breast J 2001;7:219–22CrossRefPubMed

18.

Wu CT, Morita ET, Treseler PA, Esserman LJ, Hwang ES, Kuerer HM, et al. Failure to harvest sentinel nodes identified by preoperative lymphoscintigraphy in breast cancer patients. Breast J 2003;9:86–90CrossRefPubMed

19.

Haagensen CD. In: Lymphatics of the breast. Philadelphia: Saunders; 1972. p. 300–87

20.

Turner-Warwick RT. The lymphatics of the breast. Br J Surg 1959;46:574–82PubMed

21.

Estourgie SH, Tanis PJ, Nieweg OE, Valdes –Olmos RA, Rutgers EJ, Kroon BB. Should the hunt for the internal mammary chain sentinel nodes begin? An evaluation of 150 breast cancer patients. Ann Surg Oncol 2003;10:935–41CrossRefPubMed

22.

Komenaka IK, Bauer VP, Schnabel FR, Joseph KA, Horowitz E, Ditkoff BA. Interpectoral nodes as the initial site of recurrence in breast cancer. Arch Surg 2004;139:175–8CrossRefPubMed

23.

Bale A, Gardner B, Shende M, Fromowitz F. Can interpectoral nodes be sentinel nodes? Am J Surg 1999;178:360–1CrossRefPubMed

24.

Spillane AJ, Donnellan M, Matthews AR. Clinical significance of intramammary lymph nodes. Breast 1999;8:143–6CrossRefPubMed

25.

Carcoforo P, Basaglia E, Soliani G, Bergossi L, Corcione S, Pozza E, et al. Sentinel node biopsy in the evaluation of the internal mammary node chain in patients with breast cancer [abstract]. Tumori 2002;88 suppl:5–7P

26.

Brenot-Rossi I, Houvenaeghel G, Jacquemier J, Bardou VJ, Martino M, Hassan-Sebbag N, et al. Nonvisualization of axillary sentinel node during lymphoscintigraphy. J Nucl Med 2003;44:1232–7PubMed

Title: Lymphoscintigraphic sentinel node identification in patients with breast cancer: the role of SPECT-CT
Authors: H. Lerman
U. Metser
G. Lievshitz
F. Sperber
S. Shneebaum
E. Even-Sapir
Publication date: 01-03-2006
Publisher: Springer-Verlag
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 3/2006
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-005-1927-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Lymphoscintigraphic sentinel node identification in patients with breast cancer: the role of SPECT-CT

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2006

From the heart to the brain via cardiac MIBG imaging

Is standardised 18F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?

Increased rate of dicentric chromosomes in French Polynesian thyroid cancer patients?

March 2006

99mTc-annexin V and 111In-antimyosin antibody uptake in experimental myocardial infarction in rats

Comparative value of brain perfusion SPECT and [123I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer’s disease